• By ICR Secretariat
  • Posted Thursday, September 16, 2021

Novavax begins COVID-19, flu combination vaccine trial

http://www.pharmatimes.com/news/novavax_begins_covid-19,_flu_combination_vaccine_trial_1376450

Novavax has launched a Phase I/II study evaluating a combination vaccine for the prevention of both COVID-19 and seasonal influenza, the US biotech company announced today.